New Health Sheriff in Town: Biden Issues Ten New COVID-19 Executive Orders
According to the BBC from January 21, the new President Biden has signed ten measures, mainly via executive order, in […]
0
BioHaven’s Troriluzole Fails Co-Primary Endpoints in Phase 2 Trial for Mild-to-Moderate Alzheimer’s Disease
BioHaven Pharmaceuticals announced the outcome from a focused analysis of the topline co-primary and key secondary data from its Phase […]
0
University of Utah’s Dr. Emily Spivak Leads Convalescent Plasma Study Sponsored by Johns Hopkins University
The University of Utah (“The U”) teamed up with Johns Hopkins Medicine on the ongoing national investigation into the efficacy […]
0
Ocuphire Pharma Announces ORION-1 Phase 2 Results for Nyxol Published in Clinical Ophthalmology
Ocuphire Pharmaceuticals announced that results from its ORION-1 Phase 2 clinical trial evaluating the safety and efficacy of Nyxol in glaucoma […]
0
Aclaris Therapeutics Announces Positive Top Line Data from Phase 2 Trial of ATI-450 for Treating Moderate to Severe Rheumatoid Arthritis
Aclaris Therapeutics announced positive preliminary topline results from a phase 2 trial evaluating ATI-450, an investigational oral MK2 inhibitor, in […]
0
Neurent Medical Closes $25M Series B Round to Advance In-Office Treatment for Chronic Rhinitis
Neurent Medical announced it has closed a $25 million Series B financing, led by new investor LSP, from its LSP […]
0
Novartis Antibody Bimagrumab Evidences Results in Small Phase 2 Obesity Study
A Novartis investigational product called Bimagrumab recently raised attention in the obesity research community. The human monoclonal antibody was designed to treat muscle […]
0
Plexium Completes $35M Series A Extension to Accelerate Development of Novel Protein Degraders
Plexium announced the completion of a $35M financing, led by Lux Capital and Pivotal BioVentures, with participation from The Column […]
0
Fred Hutchinson & Univ. of Washington Study Predictors of Neutralizing Antibodies to SARS-CoV-2 Among COVID-19 Convalescent Plasma Donors
A team of Seattle-based researchers led by University of Washington, Fred Hutchinson Cancer Research Center and the National Institutes of […]
0
Sheba Medical Center Study Reveals Pfizer/BioNTech Produces more Antibodies Targeting COVID-19
Recently, Sheba Medical Center based in Ramat Gan, Israel, shared some promising observations associated with the Pfizer/BioNTech COVID-19 vaccine. To […]
0